Results of targeted lymphadenectomy in patients with breast cancer cT1-3N1M0 after neoadjuvant systemic therapy
Authors:
- Sh. Sh. AbdulloevaSASh. Sh. Abdulloeva
- A. D. KaprinAKA. D. Kaprin
- A. D. ZikiryakhodzhaevAZA. D. Zikiryakhodzhaev
- E. A. RasskazovaERE. A. Rasskazova
- I. M. OnofriychukIOI. M. Onofriychuk
- Ju. I. VolkovaJVJu. I. Volkova
- U. Kh. KhomidiUKU. Kh. Khomidi
- D. B. KodzoevaDKD. B. Kodzoeva
- L. P. KazaryanLKL. P. Kazaryan
Open Access
- 4 March 2025
- journal article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 8-25
Abstract
Purpose of the study. To evaluate the results of targeted lymphadenectomy (TLAE) in patients with breast cancer (BC) cT1–3N1M0 after neoadjuvant systemic therapy (NAST). Patients and methods. The study represents a prospective analysis of 83 patients diagnosed with breast cancer in stage T1–3N1M0 who were treated in the Department of Reconstructive and Plastic Surgery of the breast and skin at the P. Hertsen Moscow Oncology Research Institute (Moscow, Russian Federation). The patients were divided into two groups: in the main group 1 (n = 45), TLAE was performed using a metal tag (clip) after surgery; in the control group 2 (n = 38), classical lymphadenectomy (LAE) was performed. The following characteristics were evaluated: the size of the primary tumor and its localization, the degree of malignan cy (G), the biological subtype of the tumor, the number of sentinel lymph nodes (SLN), the number of metastases in SLN, damage to other lymph nodes, the number of patients who moved from cN1 to cN0. According to these characteristics, the two groups were comparable and there were no statistically significant differences. The effectiveness of NAST was assessed by the frequency of complete pathomorphological regression of the lesion of the studied tissue. The frequency of identification of sentinel lymph nodes was assessed with urgent cytological and routine pathomorphological studies. Results. In group 1, a complete pathomorphological response in the mammary gland was 37.8 %, in group 2 – 31.6 %. A complete pathomorphological response in the affected lymph node (N0) after neoadjuvant polychemotherapy (NAST) was achieved in 51.1 % of patients in group 1 and 52.6 % in group 2. The frequency of identification of sentinel lymph nodes during biopsy in both groups was 100 %. The frequency of identification of the installed tag was 100 %. The frequency of coincidences of the clipped lymph node with the sentinel lymph node was 65 %. In one case, migration of the installed label was noted. The efficiency of using the navigation explorer was 93 %. Conclusion. The results obtained confirm the expediency, feasibility and high efficiency of de-escalation of surgical intervention in the form of TLAE. Our study also demonstrates the relative simplicity and accuracy of using a metal tag to achieve TLAE goals.Keywords
This publication has 42 references indexed in Scilit:
- Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare EventJAMA Oncology, 2021
- Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patientsThe Breast, 2021
- Adequate sentinel node harvest is associated with low false negative rate in breast cancer managed with neoadjuvant chemotherapy and targeted axillary dissectionThe American Journal of Surgery, 2020
- Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary stagingJournal of Surgical Oncology, 2020
- Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After TreatmentClinical Breast Cancer, 2019
- Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 studyBreast Cancer Research and Treatment, 2018
- A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation StudyClinical Breast Cancer, 2017
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- Breast CancerAcademic Radiology, 2009
- Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer (Br J Surg 2006: 93: 539–546)British Journal of Surgery, 2006